Search This Blog

Tuesday, September 3, 2019

Castle Biosciences EPS misses by $0.57, beats on revenue

Castle Biosciences (NASDAQ:CSTL): Q2 GAAP EPS of -$1.05 misses by $0.57.
Revenue of $10.74M (+169.2% Y/Y) beats by $3.26M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)